TrialJAMA neurology2017

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.

Walter N Kernan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.